Cargando…

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice

Nonalcoholic fatty liver disease (NAFLD), characterized by excessive fat deposition in the liver unrelated to alcohol consumption, is highly prevalent worldwide. However, effective therapeutic agents approved for NAFLD treatment are lacking. An ileal bile acid transporter inhibitor (IBATi), which re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsui, Masahiro, Fukunishi, Shinya, Nakano, Takashi, Ueno, Takaaki, Higuchi, Kazuhide, Asai, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406289/ https://www.ncbi.nlm.nih.gov/pubmed/34225483 http://dx.doi.org/10.1128/mBio.01155-21

Ejemplares similares

Programmed Death 1 Ligand Expression in the Monocytes of Patients with Hepatocellular Carcinoma Depends on Tumor Progression
por: Asai, Akira, et al.
Publicado: (2020)

Exacerbation of liver dysfunction in non-alcoholic steatohepatitis patients during the coronavirus disease 2019 (COVID-19) pandemic
por: Asai, Akira, et al.
Publicado: (2021)

Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats
por: Fukunishi, Shinya, et al.
Publicado: (2014)

p59fyn is associated with the development of hepatic steatosis due to chronic ethanol consumption
por: Fukunishi, Shinya, et al.
Publicado: (2011)

Sitagliptin can inhibit the development of hepatic steatosis in high-fructose diet-fed ob/ob mice
por: Sujishi, Tetsuya, et al.
Publicado: (2015)

Bilberry Anthocyanins Ameliorate NAFLD by Improving Dyslipidemia and Gut Microbiome Dysbiosis
por: Nakano, Hironobu, et al.
Publicado: (2020)

Cancer Cachexia: Its Mechanism and Clinical Significance
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Development of Fibrosis in Nonalcoholic Steatosis through Combination of a Synthetic Diet Rich in Disaccharide and Low-Dose Lipopolysaccharides in the Livers of Zucker (fa/fa) Rats
por: Fukunishi, Shinya, et al.
Publicado: (2009)

Metabolic Syndrome and Sarcopenia
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Sarcopenia and Frailty in Liver Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Endoscopic ultrasound-guided choledochoduodenostomy for obstructive jaundice with venous collaterals around the bile duct wall (with video)
por: Ogura, Takeshi, et al.
Publicado: (2017)

Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis
por: Yasuoka, Hidetaka, et al.
Publicado: (2020)

Association between Administration of Antithrombotics and Intraperitoneal Hemorrhage in Patients Undergoing Percutaneous Interventions for Liver Diseases
por: Asai, Akira, et al.
Publicado: (2021)

Perinatal High-Salt Diet Induces Gut Microbiota Dysbiosis, Bile Acid Homeostasis Disbalance, and NAFLD in Weanling Mice Offspring
por: Guo, Qing, et al.
Publicado: (2021)

Selenoneine Ameliorates Hepatocellular Injury and Hepatic Steatosis in a Mouse Model of NAFLD
por: Miyata, Masaaki, et al.
Publicado: (2020)

Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn’s disease
por: Bamba, Shigeki, et al.
Publicado: (2022)

Hybrid placement technique for hepatic hilar obstruction using a new uncovered self-expandable metal stent
por: Ogura, Takeshi, et al.
Publicado: (2019)

Liver dysfunction is associated with poor prognosis in patients after immune checkpoint inhibitor therapy
por: Yokohama, Keisuke, et al.
Publicado: (2020)

An immunosuppressive subtype of neutrophils identified in patients with hepatocellular carcinoma
por: Tsuda, Yasuhiro, et al.
Publicado: (2012)

Laparoscopic liver resection for patients with cardiac disease
por: Inoue, Yoshihiro, et al.
Publicado: (2019)

Inflammatory Bowel Disease and Sarcopenia: Its Mechanism and Clinical Importance
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

EUS-guided drainage for pancreatic walled-off necrosis by use of a novel large-diameter metal stent
por: Ogura, Takeshi, et al.
Publicado: (2017)

Acupuncture improved hepatic steatosis in HFD-induced NAFLD rats by regulating intestinal microbiota
por: Wang, Haiying, et al.
Publicado: (2023)

Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease
por: Li, Peipei, et al.
Publicado: (2021)

Impacted intrahepatic bile duct stone removal using transluminal intervention technique
por: Ogura, Takeshi, et al.
Publicado: (2019)

Comparison of SARC-F Score among Gastrointestinal Diseases
por: Ushiro, Kosuke, et al.
Publicado: (2021)

Prognostic Impact of the SARC-F Score in Gastrointestinal Advanced Cancers
por: Matsui, Masahiro, et al.
Publicado: (2021)

The Synbiotic Combination of Akkermansia muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation
por: Juárez-Fernández, María, et al.
Publicado: (2021)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis
por: Wang, Yizhong, et al.
Publicado: (2019)

Gut Microbiota Dysbiosis Associated with Bile Acid Metabolism in Neonatal Cholestasis Disease
por: Li, Meng, et al.
Publicado: (2020)

The Relationship between the SARC-F Score and the Controlling Nutritional Status Score in Gastrointestinal Diseases
por: Ikegami, Takako, et al.
Publicado: (2022)

The Relevance in the Neutrophil to Lymphocyte Ratio and the SARC-F Score in Gastrointestinal Diseases
por: Yamasaki, Eiki, et al.
Publicado: (2022)

Grip Strength in Patients with Gastrointestinal Diseases
por: Asaishi, Ken, et al.
Publicado: (2022)

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
por: Henao-Mejia, Jorge, et al.
Publicado: (2012)

Comparison of resection site of standardized laparoscopic hepatic tumor resection
por: Inoue, Yoshihiro, et al.
Publicado: (2018)

Efficacy and safety of laparoscopic hepatectomy for hepatocellular carcinoma comorbid with cirrhosis
por: Inoue, Yoshihiro, et al.
Publicado: (2020)

Hepatectomy and liver regeneration in the results of treatment of colorectal liver metastasis
por: Inoue, Yoshihiro, et al.
Publicado: (2020)

Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: case control study
por: Inoue, Yoshihiro, et al.
Publicado: (2021)

Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora
por: Miao, Xiaolei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_llm2np7joq3e28ecgea1id993d